AI assistant
Sending…
Sadot Group Inc. — Director's Dealing 2019
Sep 6, 2019
35376_dirs_2019-09-06_09e06944-301d-4d54-bdc0-2f6d0694c29e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Muscle Maker, Inc. (MMB)
CIK: 0001701756
Period of Report: 2019-04-26
Reporting Person: Mohan Kevin James (Director, Chief Investment Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-29 | Common Stock | P | 250000 | $0.0001 | Acquired | 601669 | Direct |
| 2019-04-26 | Common Stock | P | 87000 | $1.00 | Acquired | 351669 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-31 | Convertible Promissory Note | $ | P | Acquired | 2020-01-24 | Common Stock (50000) | Direct | |
| 2017-05-31 | Common Stock Purchase Warrant | $9.33 | P | Acquired | 2020-05-31 | Common Stock (2678) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 24375 | Indirect |
| Common Stock | 4875 | Indirect |
| Common Stock | 4875 | Indirect |
| Common Stock | 4875 | Indirect |
Footnotes
F1: The Convertible Promissory Note is convertible at a 50% discount to the public offering price.
F2: Shares vest upon the Company closing a public offering with proceeds in excess of $3,000,000.
More from Sadot Group Inc.
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Feb 23
Regulatory Filings
2026
Feb 12
Regulatory Filings
2026
Feb 10
Director's Dealing
2026
Jan 14